# Biohaven Pharmaceuticals (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/biohaven-pharmaceuticals-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 34 |
| Citations | 149,610 |
| City | New Haven |
| Country | US |
| Description | Biohaven Pharmaceuticals (United States) is a research organisation in New Haven, US. OpenAlex records 409 works and 149,610 citations for it. 150 researchers list it as their most recent affiliation. |
| Homepage | https://www.biohavenpharma.com/ |
| OpenAlex ID | https://openalex.org/I4210093361 |
| Region | Connecticut |
| Researchers | 150 |
| ROR ID | https://ror.org/00m2ky193 |
| Type | company |
| Works | 409 |

## University papers

Showing 12 of 19.

- [Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults](https://scholariq.org/papers/impact-of-the-metabolic-syndrome-on-mortality-from-coronary-heart-disease/)
- [Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey](https://scholariq.org/papers/association-of-the-metabolic-syndrome-with-history-of-myocardial-infarction-and/)
- [Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives](https://scholariq.org/papers/predominance-of-isolated-systolic-hypertension-among-middle-aged-and-elderly-us/)
- [A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder](https://scholariq.org/papers/a-systematic-review-antipsychotic-augmentation-with-treatment-refractory/)
- [Physician-Related Barriers to the Effective Management of Uncontrolled Hypertension](https://scholariq.org/papers/physician-related-barriers-to-the-effective-management-of-uncontrolled/)
- [Effect of compliance mismatch on vascular graft patency](https://scholariq.org/papers/effect-of-compliance-mismatch-on-vascular-graft-patency/)
- [Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine](https://scholariq.org/papers/rimegepant-an-oral-calcitonin-gene-related-peptide-receptor-antagonist-for/)
- [Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial](https://scholariq.org/papers/efficacy-safety-and-tolerability-of-rimegepant-orally-disintegrating-tablet-for/)
- [Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease](https://scholariq.org/papers/safety-and-tolerability-of-the-secretase-inhibitor-avagacestat-in-a-phase-2/)
- [Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/oral-rimegepant-for-preventive-treatment-of-migraine-a-phase-2-3-randomised/)
- [Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial](https://scholariq.org/papers/riluzole-augmentation-in-treatment-resistant-obsessive-compulsive-disorder-an/)
- [Systematic Review: Pharmacological and Behavioral Treatment for Trichotillomania](https://scholariq.org/papers/systematic-review-pharmacological-and-behavioral-treatment-for-trichotillomania/)

## University researchers

- [Gilbert L’Italien](https://scholariq.org/researchers/gilbert-l-italien/)
- [Vladimir Coric](https://scholariq.org/researchers/vladimir-coric/)

## University top topics

Showing 8 of 25.

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Traumatic Brain Injury Research](https://scholariq.org/topics/traumatic-brain-injury-research/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Neurological Complications and Syndromes](https://scholariq.org/topics/neurological-complications-and-syndromes/)
- [Neurological Disorders and Treatments](https://scholariq.org/topics/neurological-disorders-and-treatments-2/)
- [Olfactory and Sensory Function Studies](https://scholariq.org/topics/olfactory-and-sensory-function-studies/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Botulinum Toxin and Related Neurological Disorders](https://scholariq.org/topics/botulinum-toxin-and-related-neurological-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.